Andrew N Schiff - Net Worth and Insider Trading
Andrew N Schiff Net Worth
The estimated net worth of Andrew N Schiff is at least $91 Million dollars as of 2024-05-22. Andrew N Schiff is the Director of ZELTIQ Aesthetics Inc and owns about 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $91 Million. Andrew N Schiff is also the Director of Aclaris Therapeutics Inc and owns about 434,455 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $517,001. Details can be seen in Andrew N Schiff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew N Schiff has not made any transactions after 2022-11-14 and currently still holds the listed stock(s).
Transaction Summary of Andrew N Schiff
Andrew N Schiff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew N Schiff owns 18 companies in total, including Aclaris Therapeutics Inc (ACRS) , Zosano Pharma Corp (ZSANQ) , and Sunesis Pharmaceuticals Inc (SNSS) among others .
Click here to see the complete history of Andrew N Schiff’s form 4 insider trades.
Insider Ownership Summary of Andrew N Schiff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2022-11-14 | director |
| ZSANQ | Zosano Pharma Corp | 2019-04-11 | 10 percent owner |
| SNSS | Sunesis Pharmaceuticals Inc | 2019-07-15 | 10 percent owner |
 | | 2018-07-10 | 10 percent owner |
| | 2017-04-28 | director & 10 percent owner |
| | 2016-06-29 | 10 percent owner |
| | 2014-05-23 | 10 percent owner |
| | 2016-03-30 | 10 percent owner |
| | 2013-12-06 | director & 10 percent owner |
| | 2015-12-09 | 10 percent owner |
| | 2015-04-23 | 10 percent owner |
| | 2015-04-14 | 10 percent owner |
| | 2015-01-27 | 10 percent owner |
| | 2012-02-13 | 10 percent owner |
| | 2012-02-07 | 10 percent owner |
| | 2019-01-23 | 10 percent owner |
| | 2021-06-24 | other: Managing Member |
| | 2021-06-23 | director |
Andrew N Schiff Latest Holdings Summary
Andrew N Schiff currently owns a total of 2 stocks. Among these stocks, Andrew N Schiff owns 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of August 11, 2016, with a value of $91 Million and a weighting of 99.43%. Andrew N Schiff also owns 434,455 shares of Aclaris Therapeutics Inc (ACRS) as of November 14, 2022, with a value of $517,001 and a weighting of 0.57%.
Latest Holdings of Andrew N Schiff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZLTQ | ZELTIQ Aesthetics Inc | 2016-08-11 | 1,610,879 | 56.48 | 90,982,446 |
| ACRS | Aclaris Therapeutics Inc | 2022-11-14 | 434,455 | 1.19 | 517,001 |
Holding Weightings of Andrew N Schiff
Andrew N Schiff Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew N Schiff has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 500,000 shares on August 11, 2016, which brought Andrew N Schiff around $18 Million.
According to the SEC Form 4 filings, Andrew N Schiff has made a total of 6 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 53,926 shares on November 14, 2022, which brought Andrew N Schiff around $919,438.
Insider Trading History of Andrew N Schiff
- 1
Andrew N Schiff Trading Performance
GuruFocus tracks the stock performance after each of Andrew N Schiff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew N Schiff is -20.99%. GuruFocus also compares Andrew N Schiff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew N Schiff within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew N Schiff's insider trading performs compared to the benchmark.
Performance of Andrew N Schiff
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.27 | | | | | |
| Relative Return to S&P 500(%) | -4.24 | | | | | |
Andrew N Schiff Ownership Network
Andrew N Schiff Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Andrew N Schiff is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Andrew N Schiff made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 189,238 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 152,243 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Andrew N Schiff Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew N Schiff. You might contact Andrew N Schiff via mailing address: Planet Zanett Inc, 135 E 57th St, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
